Evidence map›Paper›PMID 39231772›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Expression and clinical significance of CCL17, CCL22, and CCR4 in newly diagnosed multiple myeloma].

Z F Xiao, S S Zou, C F Yi, Y Zhao, L S Wu, Y H Feng

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Z F XiaoDepartment of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
S S ZouDepartment of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
C F YiDepartment of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
Y ZhaoDepartment of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
L S WuDepartment of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
Y H FengDepartment of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China Department of Hematology, The Tenth Affiliated Hospital, Southern-Medical University (Dongguan People's Hospital), Dongguan 523000, China.

Funding

Doctoral Rearch Startup Fund of Zunyi Medical Untverity (2023) 07The Joint Fund Project of the Department of Science and Technology of Guizhou Province Guizhou Science and Technology Foundation-ZK [2021] General 406
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chemokine CCL17Chemokine CCL22Multiple MyelomaReceptors, CCR4Bone MarrowClinical RelevanceFemaleHumansMaleMiddle AgedRNA, MessengerCCL17 protein, humanCCL22 protein, humanCCR4 protein, humanChemokine CCL17Chemokine CCL22Receptors, CCR4RNA, MessengerCCL17CCL22CCR4Multiple myelomaTumorigenesis

Identifiers

PMID39231772
PMCPMC11388129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.